A Retrospective Cohort Study to Assess Drug Utilisation and Long-Term Safety of Galcanezumab in European Patients in the Course of Routine Clinical Care (I5Q-MC-B002)

17/01/2019
17/12/2025
EU PAS number:
EUPAS27594
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

I5Q-MC-B002 Galcanezumab_EU Long Term Safety_Drug Utilization_Protocol_amendment_Redacted

English (3.6 MB - PDF) View document
Study results
Study report
Other information